Is Aethlon Medical Stock a Good Investment?
Aethlon Medical Investment Advice | AEMD |
- Examine Aethlon Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Aethlon Medical's leadership team and their track record. Good management can help Aethlon Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Aethlon Medical's business and its evolving consumer preferences.
- Compare Aethlon Medical's performance and market position to its competitors. Analyze how Aethlon Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Aethlon Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Aethlon Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Aethlon Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Aethlon Medical is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Aethlon Medical Stock
Researching Aethlon Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aethlon Medical recorded a loss per share of 2.79. The entity last dividend was issued on the 15th of October 2019. The firm had 1:10 split on the 5th of October 2023.
To determine if Aethlon Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Aethlon Medical's research are outlined below:
| Aethlon Medical generated a negative expected return over the last 90 days | |
| Aethlon Medical has some characteristics of a very speculative penny stock | |
| Aethlon Medical has high historical volatility and very poor performance | |
| Aethlon Medical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.21 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
| Aethlon Medical currently holds about 14.92 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Aethlon Medical has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Cipriani Guy F. of 120883 shares of Aethlon Medical at 2.52 subject to Rule 16b-3 |
Aethlon Medical Quarterly Accounts Payable |
|
Aethlon Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Aethlon Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aethlon Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 26th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of June 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Aethlon Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Aethlon Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-09 | 2021-09-30 | -0.15 | -0.13 | 0.02 | 13 | ||
2023-06-28 | 2023-03-31 | -0.13 | -0.1 | 0.03 | 23 | ||
2022-11-14 | 2022-09-30 | -0.21 | -0.18 | 0.03 | 14 | ||
2022-08-09 | 2022-06-30 | -0.22 | -0.19 | 0.03 | 13 | ||
2022-02-14 | 2021-12-31 | -0.13 | -0.16 | -0.03 | 23 | ||
2021-08-09 | 2021-06-30 | -0.13 | -0.16 | -0.03 | 23 | ||
2020-10-28 | 2020-09-30 | -0.12 | -0.15 | -0.03 | 25 | ||
2023-02-13 | 2022-12-31 | -0.08 | -0.12 | -0.04 | 50 |
Know Aethlon Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Aethlon Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aethlon Medical backward and forwards among themselves. Aethlon Medical's institutional investor refers to the entity that pools money to purchase Aethlon Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Group One Trading, Lp | 2024-09-30 | 1.2 K | Wells Fargo & Co | 2024-09-30 | 211 | Advisor Group Holdings, Inc. | 2024-09-30 | 149 | Bank Of America Corp | 2024-09-30 | 114 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 89.0 | Bartlett & Co Wealth Management Llc | 2024-09-30 | 26.0 | Truvestments Capital Llc | 2024-09-30 | 5.0 | Hanson Mcclain Inc | 2024-09-30 | 2.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-09-30 | 218.3 K | Geode Capital Management, Llc | 2024-09-30 | 98.4 K |
Aethlon Medical's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.11 M.Market Cap |
|
Aethlon Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.48) | (1.55) | |
| Return On Capital Employed | (1.97) | (1.87) | |
| Return On Assets | (1.48) | (1.55) | |
| Return On Equity | (2.12) | (2.01) |
Determining Aethlon Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Aethlon Medical is a good buy. For example, gross profit margin measures Aethlon Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Aethlon Medical's profitability and make more informed investment decisions.
Please note, the presentation of Aethlon Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aethlon Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aethlon Medical's management manipulating its earnings.
Evaluate Aethlon Medical's management efficiency
Aethlon Medical has return on total asset (ROA) of (0.5046) % which means that it has lost $0.5046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0538) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical's management efficiency ratios could be used to measure how well Aethlon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of December 18, 2024, Return On Tangible Assets is expected to decline to -1.55. The current year's Return On Capital Employed is expected to grow to -1.87. At present, Aethlon Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 326.7 K, whereas Intangible Assets are forecasted to decline to 1,045.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.29 | 2.41 | |
| Tangible Book Value Per Share | 2.29 | 2.41 | |
| Enterprise Value Over EBITDA | 0.01 | 0.01 | |
| Price Book Value Ratio | 0.75 | 0.79 | |
| Enterprise Value Multiple | 0.01 | 0.01 | |
| Price Fair Value | 0.75 | 0.79 | |
| Enterprise Value | -154.6 K | -146.8 K |
Aethlon Medical has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 1.755 |
Basic technical analysis of Aethlon Stock
As of the 18th of December 2024, Aethlon Medical shows the Risk Adjusted Performance of 0.009, downside deviation of 4.33, and Mean Deviation of 2.83. Aethlon Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aethlon Medical treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Aethlon Medical is priced correctly, providing market reflects its regular price of 0.37 per share. As Aethlon Medical appears to be a penny stock we also recommend to validate its total risk alpha numbers.Aethlon Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aethlon Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aethlon Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aethlon Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aethlon Medical's Outstanding Corporate Bonds
Aethlon Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aethlon Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aethlon bonds can be classified according to their maturity, which is the date when Aethlon Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand Aethlon Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Aethlon Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.009 | |||
| Market Risk Adjusted Performance | 0.0033 | |||
| Mean Deviation | 2.83 | |||
| Semi Deviation | 3.12 | |||
| Downside Deviation | 4.33 | |||
| Coefficient Of Variation | 94753.86 | |||
| Standard Deviation | 4.18 | |||
| Variance | 17.47 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 25.97 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 7.5 | |||
| Downside Variance | 18.71 | |||
| Semi Variance | 9.76 | |||
| Expected Short fall | (4.92) | |||
| Skewness | 0.9636 | |||
| Kurtosis | 3.15 |
| Risk Adjusted Performance | 0.009 | |||
| Market Risk Adjusted Performance | 0.0033 | |||
| Mean Deviation | 2.83 | |||
| Semi Deviation | 3.12 | |||
| Downside Deviation | 4.33 | |||
| Coefficient Of Variation | 94753.86 | |||
| Standard Deviation | 4.18 | |||
| Variance | 17.47 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 25.97 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 7.5 | |||
| Downside Variance | 18.71 | |||
| Semi Variance | 9.76 | |||
| Expected Short fall | (4.92) | |||
| Skewness | 0.9636 | |||
| Kurtosis | 3.15 |
Consider Aethlon Medical's intraday indicators
Aethlon Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aethlon Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 19557.81 | |||
| Daily Balance Of Power | 0.6667 | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 0.36 | |||
| Day Typical Price | 0.36 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.02 |
Aethlon Stock media impact
Far too much social signal, news, headlines, and media speculation about Aethlon Medical that are available to investors today. That information is available publicly through Aethlon media outlets and privately through word of mouth or via Aethlon internal channels. However, regardless of the origin, that massive amount of Aethlon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aethlon Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aethlon Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aethlon Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aethlon Medical alpha.
Aethlon Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Aethlon Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Aethlon Medical Corporate Management
| Richard Tullis | Chief Science Officer and VP | Profile | |
| MBA BS | Chief Officer | Profile | |
| MD Fisher | Director CEO | Profile | |
| Steven MD | Chief Officer | Profile | |
| Lee Arnold | Chief Officer | Profile | |
| Sunil Sawhney | Head Studies | Profile |
Already Invested in Aethlon Medical?
The danger of trading Aethlon Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aethlon Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aethlon Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aethlon Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.50) | Return On Equity (1.05) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Aethlon Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.